sr 95531 has been researched along with Schizophrenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artigas, F; Bastlund, JF; Bussey, TJ; Celada, P; Didriksen, M; Fejgin, K; Heath, CJ; Kent, BA; Larsen, PH; Nielsen, J; Nielsen, V; Nilsson, SRO; Robbins, TW; Saksida, LM; Santana, N; Stensbøl, TB; Thelin, J | 1 |
Bondi, CO; Moghaddam, B; Pehrson, AL; Totah, NK | 1 |
2 other study(ies) available for sr 95531 and Schizophrenia
Article | Year |
---|---|
A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 15; Disease Models, Animal; Evoked Potentials, Auditory; Extinction, Psychological; GABA Antagonists; Gene Deletion; Humans; Intellectual Disability; Interneurons; Male; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Pyramidal Cells; Pyridazines; Reaction Time; Receptors, GABA-A; Reversal Learning; Schizophrenia; Schizophrenic Psychology; Seizures | 2016 |
The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention.
Topics: 3-Mercaptopropionic Acid; Animals; Attention; Carbolines; Cognition Disorders; Dizocilpine Maleate; Dose-Response Relationship, Drug; GABA Antagonists; Glutamate Decarboxylase; Gyrus Cinguli; Male; Pyridazines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2013 |